The Effect of Cyclopentolate on Ocular Biometric Components

Hassan Hashemi1, Amir Asharlous2, Mehdi Khabazkhoob3

  • 1Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.

Insights

Cyclopentolate 1% eye drops significantly alter ocular biometrics in children, reducing lens thickness and increasing anterior chamber depth. These cycloplegia-induced changes vary among refractive error groups, impacting axial length and pupil diameter.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Ocular Biometry

Background:

  • Cycloplegic eye drops induce biometric changes, but effects vary and are not well-documented across refractive error groups.
  • Understanding these variations is crucial for accurate refractive assessment in children.

Purpose of the Study:

  • To investigate the impact of cyclopentolate 1% on ocular biometric components in children with different refractive errors.
  • To analyze how cycloplegia affects axial length, lens thickness, and anterior chamber depth based on refractive status.

Main Methods:

  • A cross-sectional study involving 113 schoolchildren (226 eyes) in Iran.
  • Objective refraction and ocular biometry (Allegro Biograph) were performed before and after cyclopentolate 1% instillation.
  • Mixed-effect model regression analyzed biometric changes across refractive error groups.

Main Results:

  • Cycloplegia significantly decreased vitreous chamber depth, lens thickness, axial length, and lens power.
  • Anterior chamber depth, anterior segment length, lens central point, and pupil diameter significantly increased.
  • Changes in anterior chamber depth and vitreous chamber depth differed significantly between hyperopes and emmetropes, with lens center shifting posteriorly in myopes.

Conclusions:

  • Cycloplegia with cyclopentolate 1% reduces crystalline lens thickness, increasing anterior chamber depth.
  • Ocular biometric responses to cycloplegia are dependent on the type of refractive error.
Abstract